Labshake search
Citations for Stemcell Technologies :
401 - 450 of 1042 citations for 7H Pyrrolo 2 3 d pyrimidin 2 amine 7 3 5 bis O 2 4 dichlorophenyl methyl 2 C methyl b D ribofuranosyl 4 chloro since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2020Quote: ... and 3 μM CHIR-99021 (Stem Cell Technologies), and then for the 3 following days to 100 ng/ml Activin A alone ...
-
bioRxiv - Neuroscience 2022Quote: ... 3 µM CHIR99021 (STEMCELL Technologies, Vancouver, Canada, 72054), and 1 µM retinoic acid ...
-
bioRxiv - Immunology 2023Quote: ... Human Peripheral Blood Plasma (3%; Stem Cell Technologies), 3,3‘,5-Triiodo-L-thyronine (1 µM ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies, Canada), 500 μg.mL-1 bovine serum albumin (BSA ...
-
bioRxiv - Neuroscience 2023Quote: ... 3 μM CHIR99021 (STEMCELL Technologies; Cat. No. 72054), 2 μM DMH1 (Sigma-Aldrich ...
-
bioRxiv - Cell Biology 2020Quote: ... Cells were suspended in Hanks Balanced Salt Solution (HBSS) supplemented with 5% human serum and 1.5 µg/mL anti-human CD32 antibody (Clone IV.3; STEMCELL Technologies) and then stained with designated antibodies for 1-2 hours on ice prior to sorting on a Becton Dickinson FACSAria™ Fusion or FACSAria™ III sorter ...
-
bioRxiv - Developmental Biology 2022Quote: ... organoids were treated from days 3 - 5 with ROCKi-free neural differentiation medium supplemented with retinoic acid (RA) (Stemcell Technologies) at 0.25 μM and smoothened agonist (SAG ...
-
bioRxiv - Cancer Biology 2022Quote: ... using base medium (1:1 ratio of DMEM/F12 Glutamax/Neurobasal medium [Gibco], 2% B27 supplement without vitamin A [Gibco], 10% BIT 9500 [StemCell Technologies], and 1 mM glutamine [Gibco]) supplemented with 20ng/ml EGF (Chemicon) ...
-
bioRxiv - Genetics 2023Quote: ... the top 40% of ATTO-550 positive cells were sorted as single-cells into individual wells of two 96-well plates with different combination of CellAdhere Laminin-521 (STEMCELL Technologies, Cat#77004, (2 μg/cm2)) or Vitronectin (0.5 μg/cm2) ...
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). On the following day ...
-
bioRxiv - Cancer Biology 2019Quote: ... IL-3/G-CSF–producing M2-10B4 and IL-3/KL-producing SI/SI murine fibroblasts in MyeloCult H5100 (StemCell Technologies) supplemented with hydrocortisone ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). After sublethal conditioning of 9-12 weeks old Gaa−/− mice with 7.5 Gy gamma-irradiation (1.6 Gy/min ...
-
bioRxiv - Bioengineering 2023Quote: ... The samples were then incubated overnight at 4°C with primary antibody (beta-tubulin III 1:500; STEMCELL Technologies 60052) diluted in blocking buffer ...
-
bioRxiv - Molecular Biology 2019Quote: ... iPSCs were passaged every 5-7 days using ReLeSR (Stem Cell Technologies).
-
bioRxiv - Genetics 2021Quote: ... ∼4 × 105 CS iPSCs containing a c.1569G>A (p.(W523X)) mutation were treated with Accutase (working dilution 1:3 in PBS; StemCell Technologies #07922,). Cells were dissociated to generate a suspension of single cells ...
-
bioRxiv - Developmental Biology 2023Quote: ... we added 4-hydroxytamoxifen freshly prepared in ethanol as per manufacturer instructions (4-OHT) (Stem Cell Technologies, 72662) to the medium at 0.1µM at the indicated time points.
-
bioRxiv - Bioengineering 2021Quote: ... coated tissue culture plates and passaged regularly as cell aggregates every 4-5 days using ReLeSR (Stemcell Technologies, 05872).
-
bioRxiv - Biochemistry 2023Quote: ... 4 μg/mL heparin (STEMCELL Technologies, 07980) and 5 μM ROCK inhibitor (Millipore) ...
-
bioRxiv - Genomics 2020Quote: Unsorted floating cells were taken from d2-3 of the blast culture and 5×103 cells were seeded in 1 ml MethoCult (M3434 STEMCELL Technologies) per dish ...
-
bioRxiv - Cell Biology 2023Quote: ... final concentrations of either 3 µM CHIR99021 for definitive hematopoietic differentiation or 3 µM IWP2 (Selleckchem, S7085) and 1 ng/ml activin A (Stemcell Technologies, 78001) for primitive hematopoietic differentiation were added to the media for 30 hours ...
-
bioRxiv - Genomics 2019Quote: ... They were passaged using 1:3 Accutase (STEMCELL Technologies).
-
bioRxiv - Cell Biology 2021Quote: ... 1 μM PD03259010 and 3 μM CHIR99021 (STEMCELL Technologies) and 100 U/ml penicillin ...
-
bioRxiv - Developmental Biology 2022Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies, Cat.#72054), 500 μg/mL bovine serum albumin (BSA ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml NT-3 (Stem Cell Technologies Cat # 78074), and Penicillin/Streptomycin (Thermo Fisher ...
-
bioRxiv - Cancer Biology 2021Quote: ... containing 3 mL Methocult GF H4230 (Stem Cell Technologies) and plated in triplicate in 35 mm gridded plates and incubating for 8-10 d.
-
bioRxiv - Immunology 2023Quote: ... and IL-3 (10 ng/mL; Stem Cell Technologies). After 5 days ...
-
bioRxiv - Cancer Biology 2023Quote: ... Cells were then washed with basal medium (500g, 4°C) and replated in Matrigel in mouse IntestiCult Organoid Growth Medium (STEMCELL Technologies) supplemented with Y-27632 (10 μM) ...
-
bioRxiv - Cell Biology 2023Quote: ... The medium was replaced on d1 with RPMI/B27™ minus insulin supplemented with 5 µM IWP-4 (STEMCELL Technologies). On d3 medium change was performed using RPMI/B27™ minus insulin without any supplementation ...
-
bioRxiv - Developmental Biology 2024Quote: ... cells were split every 5-7 days with accutase (Stem Cell Technologies, #07920) (Bajpai et al. ...
-
bioRxiv - Developmental Biology 2022Quote: ... cells were transferred onto matrigel (R&D) and cultured with mTeSR1 (Stemcell Technologies) for banking.
-
bioRxiv - Cell Biology 2020Quote: ... Neural rosettes were derived between day 3 to day 5 by addition of STEMdiffTM Neural Rosette Selection Reagent (05832, Stem Cell Technologies) for 45 mins-1 hr at 37oC ...
-
bioRxiv - Bioengineering 2020Quote: MSCs at passages 1 or 3 were seeded in wells of a 12-well plate containing 3 ml Mesencult (Stem Cell Technologies, Vancouver, B.C.) each at 8.0×104 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 μg/ml heparin (Stem cell technologies; #07980), 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 4 µg/mL heparin (STEMCELL Technologies), 480 ng/mL hydrocortisone ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 μg/ml heparin (Stem cell technologies; #07980), 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 µg/mL Heparin (StemCell Technologies, cat. 07980), and 400 nL/mL B27 (Invitrogen ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 µg/mL Heparin (StemCell Technologies, cat. 07980), and 400 nL/mL B27 (Invitrogen ...
-
bioRxiv - Cell Biology 2021Quote: ... washed with phosphate buffered saline (PBS) and incubated overnight at 4 °C with a mouse monoclonal anti-CD3 (clone UCHT1, StemCell Technologies, #60011) 10 μg/mL in PBS ...
-
bioRxiv - Cell Biology 2020Quote: ... the imaging chamber was incubated overnight at 4° C with 10 μg/mL of a mouse monoclonal anti-CD3 (clone UCHT1, StemCell Technologies, #60011) in PBS ...
-
bioRxiv - Cell Biology 2020Quote: ... washed with phosphate buffered saline (PBS) and incubated overnight at 4° C with a mouse monoclonal anti-CD3 antibody (clone UCHT1, StemCell Technologies, #60011) or a mouse monoclonal anti-HA antibody (clone 16B12 ...
-
bioRxiv - Genetics 2024Quote: ... cells were harvested by centrifugation at 380 x g for 10 min at 4°C and resuspended in EasySepT Buffer (Stem Cell Technologies). HSPCs were purified by negative selection using the EasySep Mouse Hematopoietic Progenitor Cell Isolation Kit (Stem Cell Technologies) ...
-
bioRxiv - Cell Biology 2020Quote: ... N2B27 medium was supplemented with 3 µM CHIR (STEMCELL Technologies) and 100 ng/mL Activin A (Biotechne) ...
-
bioRxiv - Cell Biology 2020Quote: ... Cells were passaged every 3 days using Relesr (STEMCELL Technologies) and supplemented with Rock Inhibitor Y-27632 (SelleckChem ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/ml IL-3 (STEMCELL Technologies; Cat. No. 78042) was directly added to the medium to support growth in the absence of an oncogene ...
-
bioRxiv - Microbiology 2022Quote: ... 20 ng/ml NT-3 (Stem Cell Technologies Cat # 78074), and Penicillin/Streptomycin cocktail ...
-
bioRxiv - Developmental Biology 2023Quote: ... 3 μM CHIR99021 (Chir) (Catalog no. 72054, Stem Cell Technologies), 1 μM PD0305901 (Catalog no ...
-
bioRxiv - Genomics 2020Quote: ... H1 cells were daily fed with fresh mTeSR1 media and passaged every 4-5 days using ReLeSR reagent (StemCell Technologies, 05872). Cells were dissociated into single cells with TrypLE Express (Thermo Fisher ...
-
bioRxiv - Cell Biology 2021Quote: ... H9-hESC SOX10::GFP reporter and H20961 iPSC were passaged ∼1:6 every 4-5 days by incubating them in ReLeSR (StemCell technologies) for 1 min at room temperature ...
-
bioRxiv - Developmental Biology 2022Quote: ... they were specified into a hiPSC-CM/stromal cell mixture using RPMI B27-containing 5 µM IWP-4 (Stem Cell Technologies) followed by another 7 days of RPMI B27+ (RPMI1640 GlutaMAX + 2% B27 supplement with insulin ...
-
bioRxiv - Cancer Biology 2021Quote: IL-10 polarized human DCs (3×10^4/well) were incubated with allogeneic CD8+ T cells (1.5 × 10^5/well) in T cell media (Stem Cell Technologies) in 96 well flat bottom tissue culture plates for 4 days ...